Pharmacokinetics of a Single 14C-labeled Dose of Risedronate or Alendronate Followed by Once-a-week Unlabeled Oral Dose
Condition(s):Osteopenia; OsteoporosisLast Updated:April 17, 2013Completed
Hide Studies Not Open or Pending
Condition(s):Osteopenia; OsteoporosisLast Updated:April 17, 2013Completed
Condition(s):OsteoporosisLast Updated:April 17, 2013Completed
Condition(s):Osteogenesis ImperfectaLast Updated:April 22, 2013Completed
Condition(s):Postmenopausal OsteoporosisLast Updated:April 22, 2013Completed
Condition(s):Osteoporosis, PostmenopausalLast Updated:January 11, 2011Completed
Condition(s):OsteoporosisLast Updated:October 19, 2018Completed
Condition(s):OsteoporosisLast Updated:March 4, 2014Completed
Condition(s):Other OsteoporosisLast Updated:October 28, 2011Completed
Condition(s):BioavailabilityLast Updated:October 12, 2011Completed
Condition(s):PostmenopausalLast Updated:April 17, 2013Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.